BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 18250192)

  • 1. Oct2 enhances antibody-secreting cell differentiation through regulation of IL-5 receptor alpha chain expression on activated B cells.
    Emslie D; D'Costa K; Hasbold J; Metcalf D; Takatsu K; Hodgkin PO; Corcoran LM
    J Exp Med; 2008 Feb; 205(2):409-21. PubMed ID: 18250192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B and T cells collaborate in antiviral responses via IL-6, IL-21, and transcriptional activator and coactivator, Oct2 and OBF-1.
    Karnowski A; Chevrier S; Belz GT; Mount A; Emslie D; D'Costa K; Tarlinton DM; Kallies A; Corcoran LM
    J Exp Med; 2012 Oct; 209(11):2049-64. PubMed ID: 23045607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 5 in the link between the innate and acquired immune response.
    Takatsu K; Kouro T; Nagai Y
    Adv Immunol; 2009; 101():191-236. PubMed ID: 19231596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential involvement of the transcription factor Blimp-1 in T cell-independent and -dependent B cell differentiation to plasma cells.
    Soro PG; Morales-A P; Martínez-M JA; Morales-A S; Copín SG; Marcos MA; Gaspar ML
    J Immunol; 1999 Jul; 163(2):611-7. PubMed ID: 10395648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-bet Transcription Factor Promotes Antibody-Secreting Cell Differentiation by Limiting the Inflammatory Effects of IFN-γ on B Cells.
    Stone SL; Peel JN; Scharer CD; Risley CA; Chisolm DA; Schultz MD; Yu B; Ballesteros-Tato A; Wojciechowski W; Mousseau B; Misra RS; Hanidu A; Jiang H; Qi Z; Boss JM; Randall TD; Brodeur SR; Goldrath AW; Weinmann AS; Rosenberg AF; Lund FE
    Immunity; 2019 May; 50(5):1172-1187.e7. PubMed ID: 31076359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD38 ligation induces tyrosine phosphorylation of Bruton tyrosine kinase and enhanced expression of interleukin 5-receptor alpha chain: synergistic effects with interleukin 5.
    Kikuchi Y; Yasue T; Miyake K; Kimoto M; Takatsu K
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11814-8. PubMed ID: 8524855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Oct2 from the channel catfish: functional preference for a variant octamer motif.
    Ross DA; Magor BG; Middleton DL; Wilson MR; Miller NW; Clem LW; Warr GW
    J Immunol; 1998 Apr; 160(8):3874-82. PubMed ID: 9558093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-5 regulates genes involved in B-cell terminal maturation.
    Horikawa K; Takatsu K
    Immunology; 2006 Aug; 118(4):497-508. PubMed ID: 16895557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blimp-1 over-expression abrogates IL-4- and CD40-mediated suppression of terminal B cell differentiation but arrests isotype switching.
    Knödel M; Kuss AW; Berberich I; Schimpl A
    Eur J Immunol; 2001 Jul; 31(7):1972-80. PubMed ID: 11449349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hierarchical process of differentiation of long-lived antibody-secreting cells is dependent on integrated signals derived from antigen and IL-17A.
    Grund LZ; Lopes-Ferreira M; Lima C
    PLoS One; 2013; 8(9):e74566. PubMed ID: 24058589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISP-3, a protein with homology to plant defense proteins, is expressed in mouse B cells under the control of Oct2.
    Pfisterer P; König H; Hess J; Lipowsky G; Haendler B; Schleuning WD; Wirth T
    Mol Cell Biol; 1996 Nov; 16(11):6160-8. PubMed ID: 8887646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for Blimp1 in the transcriptional network controlling natural killer cell maturation.
    Kallies A; Carotta S; Huntington ND; Bernard NJ; Tarlinton DM; Smyth MJ; Nutt SL
    Blood; 2011 Feb; 117(6):1869-79. PubMed ID: 21131593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas.
    Loddenkemper C; Anagnostopoulos I; Hummel M; Jöhrens-Leder K; Foss HD; Jundt F; Wirth T; Dörken B; Stein H
    J Pathol; 2004 Jan; 202(1):60-9. PubMed ID: 14694522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLy2 controls the antibody response to pneumococcal vaccine through an IL-5Rα-dependent mechanism in B-1 cells.
    Schmitt F; Schäll D; Bucher K; Schindler TI; Hector A; Biedermann T; Zemlin M; Hartl D; Beer-Hammer S
    Eur J Immunol; 2015 Jan; 45(1):60-70. PubMed ID: 25330943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BLIMP1 guides the fate of effector B and T cells.
    Nutt SL; Fairfax KA; Kallies A
    Nat Rev Immunol; 2007 Dec; 7(12):923-7. PubMed ID: 17965637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The AP-1 transcription factor Fra1 inhibits follicular B cell differentiation into plasma cells.
    Grötsch B; Brachs S; Lang C; Luther J; Derer A; Schlötzer-Schrehardt U; Bozec A; Fillatreau S; Berberich I; Hobeika E; Reth M; Wagner EF; Schett G; Mielenz D; David JP
    J Exp Med; 2014 Oct; 211(11):2199-212. PubMed ID: 25288397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blimp-1 Contributes to the Development and Function of Regulatory B Cells.
    Wang YH; Tsai DY; Ko YA; Yang TT; Lin IY; Hung KH; Lin KI
    Front Immunol; 2019; 10():1909. PubMed ID: 31474988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The unfolded protein response of B-lymphocytes: PERK-independent development of antibody-secreting cells.
    Gass JN; Jiang HY; Wek RC; Brewer JW
    Mol Immunol; 2008 Feb; 45(4):1035-43. PubMed ID: 17822768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-1R/TLR2 through MyD88 Divergently Modulates Osteoclastogenesis through Regulation of Nuclear Factor of Activated T Cells c1 (NFATc1) and B Lymphocyte-induced Maturation Protein-1 (Blimp1).
    Chen Z; Su L; Xu Q; Katz J; Michalek SM; Fan M; Feng X; Zhang P
    J Biol Chem; 2015 Dec; 290(50):30163-74. PubMed ID: 26483549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of normal B-cell differentiation and malignant B-cell survival by OCT2.
    Hodson DJ; Shaffer AL; Xiao W; Wright GW; Schmitz R; Phelan JD; Yang Y; Webster DE; Rui L; Kohlhammer H; Nakagawa M; Waldmann TA; Staudt LM
    Proc Natl Acad Sci U S A; 2016 Apr; 113(14):E2039-46. PubMed ID: 26993806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.